Your eGFR, or estimated glomerular filtration rate, is a number that approximates how well your kidneys filter waste from your blood, expressed in milliliters per minute adjusted for body size. The CKD-EPI equation is the formula most labs now use to calculate it from a routine blood test measuring creatinine. A result above 90 is generally considered normal, while numbers below 60 sustained for three months or more point toward chronic kidney disease. But the number on your lab report is an estimate with real limitations, and understanding what can make it misleading is just as important as knowing the ranges.
Why Labs Use an Estimate Instead of Measuring Directly
The gold standard for knowing your actual kidney filtration rate involves injecting a tracer substance and drawing multiple blood samples over several hours to track how quickly your kidneys clear it. This measured GFR is accurate, but it requires patients to stay in a clinic for an extended period, and the procedures remain expensive and impractical for routine care or large-scale screening.1PubMed Central. Measured GFR in Routine Clinical Practice – The Promise of Dried Blood Spots So instead, your doctor relies on equations that estimate GFR from a simple blood marker, most commonly creatinine, a waste product generated by your muscles and filtered out by your kidneys.
The CKD-EPI equation, first published in 2009, was developed because older formulas tended to underestimate kidney function in people whose kidneys were actually healthy. In validation studies, the CKD-EPI equation showed less bias and greater accuracy than the previous formula, with about 84% of its estimates falling within 30% of measured GFR, compared to roughly 81% for the older equation.2Annals of Internal Medicine. A new equation to estimate glomerular filtration rate That improvement matters most at higher GFR values, meaning it is better at correctly telling people with near-normal kidney function that they are fine.
What the Numbers Mean
Kidney function is staged based on your eGFR value, and these categories come from international guidelines used by doctors worldwide. The stages reflect how much filtering capacity remains:
- Above 90: Normal or high kidney function. No kidney disease by this measure alone, though other signs like protein in the urine can still indicate a problem.
- 60 to 89: Mildly reduced. Many healthy people, especially older adults, fall here. This range alone does not equal chronic kidney disease unless there is other evidence of kidney damage.
- 45 to 59 (stage G3a): Mild to moderate reduction. Doctors start paying closer attention and may order more frequent monitoring.
- 30 to 44 (stage G3b): Moderate to severe reduction. Medication adjustments become more common, and referral to a kidney specialist is typically considered.
- 15 to 29 (stage G4): Severely reduced. Planning for potential dialysis or transplant usually begins.
- Below 15 (stage G5): Kidney failure. Most people at this level need dialysis or a transplant to survive.
A single low reading does not mean you have chronic kidney disease. The diagnosis requires two tests at least three months apart showing eGFR below 60 or other markers of kidney damage like elevated protein in the urine. Temporary drops can happen from dehydration, certain medications, or an acute illness, and they often bounce back.
The 2021 Update and Why Race Was Removed
The original 2009 CKD-EPI equation included a race-based adjustment that gave higher eGFR values to Black patients, on the assumption that higher average muscle mass in that group would produce more creatinine. This adjustment was widely criticized for embedding a racial generalization into a medical formula and for potentially delaying care in Black patients who actually had kidney disease. In 2021, researchers published a new version of the CKD-EPI equation that removed the race variable entirely.3PubMed Central. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race
The practical effect is that the 2021 equation gives somewhat higher eGFR values than the 2009 version did for most people. In a large European cohort, the median increase was about 4 mL/min/1.73 m², and roughly 10% of the study population was reclassified into a less severe kidney disease category. Among those who already had stage G3 through G5 disease, over a third were bumped up a category.4PubMed Central. Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population If your lab recently switched to the 2021 equation, your eGFR might appear slightly higher than a previous result calculated with the old formula, even though your actual kidney function has not changed. This reclassification is most common around the 60 mL/min/1.73 m² threshold, which is the dividing line between stage G2 and G3a.5BMC Nephrology. When equations disagree: the impact of creatinine-based eGFR in CKD diagnosis and reclassification
The Age Factor
Kidney filtration naturally declines with age, starting roughly in the third decade of life and losing about 1 mL/min per year.6Scientific Reports. Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study By age 70, a typical person may have lost over 40 mL/min compared to their peak. This decline appears to be a normal part of organ aging and is associated with structural changes in the kidneys themselves.7PubMed Central. Ageing and the glomerular filtration rate: truths and consequences
This creates a genuine dilemma. A healthy 75-year-old with an eGFR of 55 may have perfectly normal kidneys for their age, yet they technically meet the threshold for a CKD diagnosis. Whether that label is appropriate or helpful remains debated in nephrology. Some researchers have argued that a blanket eGFR cutoff below 60 is not appropriate for elderly patients, because it labels a large number of healthy older adults as having kidney disease and can trigger unnecessary monitoring, medication restrictions, and anxiety. The equations used by different labs can also diverge for older women: one study found that the EKFC equation (a European alternative to CKD-EPI) assigned more women over 65 to stage G3a than the CKD-EPI 2021 equation did.5BMC Nephrology. When equations disagree: the impact of creatinine-based eGFR in CKD diagnosis and reclassification
The practical takeaway: if you are over 65 and your eGFR is in the 45 to 60 range with no protein in your urine, no high blood pressure, and stable readings over time, your doctor may reasonably reassure you rather than escalate treatment. Context matters more than the number alone.
Why Your eGFR Might Be Wrong
Because the CKD-EPI equation uses serum creatinine as its input, anything that changes creatinine levels for reasons unrelated to kidney function will throw off the estimate. The most common culprit is muscle mass. Creatinine is a byproduct of muscle metabolism, so people with significantly more muscle produce more of it, and people with very little muscle produce less. The equation assumes average muscle mass. If you are a competitive weightlifter, your eGFR may look artificially low because your high creatinine is being misread as poor filtration. If you are frail or have lost muscle from illness, your eGFR may look reassuringly normal even though your kidneys are struggling.
Research has quantified this effect. In one study of kidney transplant recipients, each additional 10 kg of lean muscle mass was associated with a false eGFR reduction of about 6 mL/min.8EClinicalMedicine. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy A longitudinal study confirmed that people with low muscle mass showed large discrepancies between creatinine-based and cystatin C-based eGFR, with the gap widening further in older patients.9PubMed Central. Muscle mass and estimates of renal function: a longitudinal cohort study Fat mass, interestingly, had no meaningful effect on the error. Performance of every creatinine-based eGFR equation tested was worst in the lowest muscle mass group.10PubMed Central. Impact of Muscle Mass on the Performance of Creatinine-Based eGFR Equations and Mortality Risk Assessment After Kidney Transplantation
Medications can also interfere. Several drugs raise serum creatinine without affecting actual kidney function. Trimethoprim (a common antibiotic) and cimetidine (a heartburn drug) block the kidney tubules from secreting creatinine, causing it to accumulate in the blood. Corticosteroids and certain other medications can also push creatinine up through different mechanisms.11PubMed. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? If your eGFR suddenly drops after starting a new medication, that is worth flagging with your doctor before assuming your kidneys are failing.
Diet matters too, particularly high intake of cooked meat, which can temporarily boost creatinine production. Lab assay methods have also improved over the years; standardization to a reference method has reduced measurement variability, but older tests may have produced less reliable creatinine values.12PubMed Central. Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate? Various other substances and conditions can also cause creatinine readings to be falsely elevated.13PubMed Central. False estimates of elevated creatinine
Cystatin C as a Second Opinion
When a creatinine-based eGFR seems unreliable, doctors can order a second blood marker called cystatin C. Unlike creatinine, cystatin C is produced by nearly all cells in the body at a relatively constant rate, so it is much less affected by muscle mass. International guidelines have recommended using cystatin C to confirm a CKD diagnosis made by creatinine alone and for clinical situations where accuracy is especially important, such as before dosing certain medications.14PubMed Central. Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR
The 2021 CKD-EPI update includes equations based on cystatin C alone and on creatinine plus cystatin C combined. The combined equation was the most accurate and showed smaller differences between racial groups.3PubMed Central. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race In studies comparing the three approaches in real patients with confirmed CKD, the combined equation aligned with the clinical diagnosis in every confirmed case, while creatinine alone overestimated function in the majority.15PubMed Central. Comparison of Creatinine-, Cystatin C-, and Combined Creatinine-Cystatin C-Based Equations for Estimating Glomerular Filtration Rate: A Real-World Analysis in Patients with Chronic Kidney Disease In large population studies, reclassifying patients based on cystatin C rather than creatinine was meaningfully linked to actual health outcomes: people whose eGFR went up with cystatin C had lower risk of death and cardiovascular events, while those reclassified downward faced higher risk.16PubMed Central. Cystatin C versus creatinine in determining risk based on kidney function
Cystatin C is not perfect, though. It has its own set of confounders. Corticosteroids can raise cystatin C levels independently of kidney function by stimulating its production.17PubMed Central. Corticosteroids significantly increase cystatin C levels in the plasma by promoting cystatin C production in rats Obesity is another factor: adipose tissue itself produces cystatin C, so heavier individuals may show falsely elevated levels.18PubMed. Serum cystatin C concentrations are increased in human obesity in relation to over-production by the adipose tissue Thyroid disorders, active inflammation, and certain cancers can also affect it. In people with type 2 diabetes, cystatin C-based equations, including the combined version, actually performed worse than creatinine alone, underestimating true GFR, particularly when kidney function was normal or high-normal.19PubMed. Combined creatinine-cystatin C CKD-EPI equation significantly underestimates measured glomerular filtration rate in people with type 2 diabetes mellitus No single marker is reliable in every patient, which is why trends over time and the full clinical picture matter more than any single reading.
Urine Albumin Adds Critical Context
Your eGFR tells you how much filtering your kidneys are doing, but it says nothing about whether the filters themselves are damaged. That is where the urine albumin-to-creatinine ratio (uACR) comes in. Albumin is a protein that healthy kidneys keep in the blood; when it spills into the urine, it signals that the kidney’s filtering units are leaking. A uACR above 30 mg/g is considered abnormal.
The combination of eGFR and uACR is far more informative than either alone. Research in patients with type 2 diabetes showed that combining the two was more accurate at predicting the risk of cardiovascular events and death than eGFR alone, and that the uACR-associated risk worsened as CKD stage progressed.20PubMed Central. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study Current clinical guidelines use a grid of eGFR stages and albuminuria categories together to assign risk and guide referral decisions. Someone with an eGFR of 55 and no albumin in their urine is in a very different situation from someone with the same eGFR and heavy proteinuria.
Acute Kidney Injury and Afterward
A sudden drop in eGFR during a hospitalization, known as acute kidney injury, raises questions about long-term recovery. A nationwide study found that among people who had normal or near-normal kidney function before their first episode, the median eGFR was about 6 mL/min lower afterward, though the range was wide, with some people losing much more and others bouncing back entirely.21PubMed Central. Kidney function before and after acute kidney injury: a nationwide population-based cohort study A separate long-term study found that mild to moderate acute kidney injury was associated with a small but real loss of function, around 1 to 2 mL/min, that did not recover to baseline. However, the rate of subsequent decline did not significantly change.22Kidney International. Association of hospitalized acute kidney injury with subsequent kidney function trajectory: the ASSESS-AKI study In other words, a mild episode might knock your eGFR down a small notch permanently, but it does not necessarily set you on a faster downhill trajectory.
When to See a Kidney Specialist
International guidelines recommend referral to a nephrologist when eGFR is persistently below 30, when there is heavy proteinuria (uACR above 300 mg/g), or when kidney function is declining rapidly, among other criteria.23PubMed Central. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease Referral should also be considered when eGFR falls below 60, particularly if other risk factors are present.24Nephrology Dialysis Transplantation. When to refer to a nephrology clinic The speed of decline matters as much as the absolute number. A stable eGFR of 50 over several years is a different clinical picture from an eGFR that dropped from 80 to 50 in twelve months.
For people already diagnosed with CKD, a class of medications called SGLT2 inhibitors has emerged as a key treatment to slow further kidney decline. These drugs were originally designed for diabetes but protect the kidneys through a separate mechanism, reducing pressure inside the kidney’s filtering units regardless of blood sugar effects.25PubMed Central. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations One aspect that confuses patients and sometimes doctors: SGLT2 inhibitors typically cause a small initial dip in eGFR during the first weeks of treatment. Research suggests this early dip is actually a hemodynamic response to the drug reducing pressure in the kidney, and a larger initial dip was associated with a more favorable kidney trajectory afterward.26Journal of Pharmaceutical Health Care and Sciences. Association between initial eGFR dip and renal function trajectory in patients with chronic kidney disease initiating SGLT2 inhibitors: a retrospective cohort study People whose kidneys were declining fastest before starting the drug showed the greatest benefit in slowing that decline.27PubMed. Larger Degree of Renal Function Decline in Chronic Kidney Disease Is a Favorable Factor for the Attenuation of eGFR Slope Worsening by SGLT2 Inhibitors: A Retrospective Observational Study
How to Track Your Own Results
If you have access to your lab results through a patient portal, tracking your eGFR over time is more useful than fixating on any individual reading. A single result is a snapshot that can be noisy due to hydration, diet, a recent illness, or lab variation. The trend across several tests paints a clearer picture. Most doctors look at the eGFR slope, which is essentially how fast the number is falling per year. A decline of more than 5 mL/min per year is generally considered rapid and worth investigating, while a stable or slowly declining eGFR may need nothing more than periodic checkups.
When comparing results across time, make sure you know which equation was used. If your lab switched from the 2009 CKD-EPI equation to the 2021 version, an apparent improvement of a few points might just be the formula change, not your kidneys getting better. Ask your provider or check the lab report footnotes. Some portals now list which equation version was applied.
Keep in mind that eGFR values above 60 are less precise than those below 60. Many labs simply report “>60” or “>90” rather than giving an exact number in the higher ranges, because the margin of error becomes wide enough that distinguishing between, say, 95 and 110 is not clinically meaningful. The equation was built and validated primarily to detect and stage kidney disease, not to split hairs about whose healthy kidneys are filtering at exactly what rate.